
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/3-MeO-PCP: Difference between revisions
Jump to navigation
Jump to search
>Unity common name removed |
>Isaak Common names correctly annotated. |
||
(7 intermediate revisions by 5 users not shown) | |||
Line 35: | Line 35: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption=Molecular structure of 3-MeO-PCP | |MolecularStructureCaption=Molecular structure of 3-MeO-PCP | ||
|SkeletalImageFile=File:3-MeO-PCP. | |SkeletalImageFile=File:3-MeO-PCP.svg | ||
|SkeletalImageWidth=245px | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
Line 41: | Line 41: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=3-MeO-PCP, 3-MeO | |NameCommon=[[common name::3-MeO-PCP]], [[common name::3-MeO]] | ||
|NameSubstitution=3-Methoxyphencyclidine | |NameSubstitution=3-Methoxyphencyclidine | ||
|NameSystematic=1-[1-(3- | |NameSystematic=1-[1-(3-Methoxyphenyl)cyclohexyl]-piperidine | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Dissociative]] | |EffectClass=[[psychoactive class::Dissociative]] | ||
|ChemicalClass=[[Arylcyclohexylamine]] | |ChemicalClass=[[chemical class::Arylcyclohexylamine]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
Line 56: | Line 56: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::2]] | |OralROA_Threshold=[[Oral threshold dose::2]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::4]] - [[Oral max light dose::8]] mg | |OralROA_Light=[[Oral min light dose::4]] - [[Oral max light dose::8]] mg | ||
|OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | |OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | ||
Line 70: | Line 70: | ||
|OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | ||
|InsufflatedROA=true | |||
|InsufflatedROA_Collapsed=true | |||
|InsufflatedROA_Caption= | |||
|InsufflatedROA_Bioavailability= | |||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::1]] [[Insufflated dose units::mg]] | |||
|InsufflatedROA_Light=[[Insufflated min light dose::2]] - [[Insufflated max light dose::5]] mg | |||
|InsufflatedROA_Common=[[Insufflated min common dose::5]] - [[Insufflated max common dose::10]] mg | |||
|InsufflatedROA_Strong=[[Insufflated min strong dose::10]] - [[Insufflated max strong dose::15]] mg | |||
|InsufflatedROA_Heavy=15 mg + <span style="color:red">'''Heavy doses may result in psychosis and mania.'''<ref name="psychosis">3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential</ref></span> | |||
|InsufflatedROA_TimelineFile= | |||
|InsufflatedROA_TimelineWidth= | |||
|InsufflatedROA_Duration=[[Insufflated min total time::3]] - [[Insufflated max total time::5]] [[Insufflated total time units::hours]] | |||
|InsufflatedROA_Onset=[[Insufflated min onset time::5]] - [[Insufflated max onset time::30]] [[Insufflated onset time units::minutes]] | |||
|InsufflatedROA_Comeup=[[Insufflated min comeup time::45]] - [[Insufflated max comeup time::90]] [[Insufflated comeup time units::minutes]] | |||
|InsufflatedROA_Peak=[[Insufflated min peak time::1.5]] - [[Insufflated max peak time::2]] [[Insufflated peak time units::hours]] | |||
|InsufflatedROA_Offset=[[Insufflated min offset time::45]] - [[Insufflated max offset time::60]] [[Insufflated offset time units::minutes]] | |||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::4]] - [[Insufflated max afterglow time::48]] [[Insufflated afterglow time units::hours]] | |||
|SmokedROA=true | |SmokedROA=true | ||
Line 110: | Line 92: | ||
|SmokedROA_Caption= | |SmokedROA_Caption= | ||
|SmokedROA_Bioavailability= | |SmokedROA_Bioavailability= | ||
|SmokedROA_Threshold=[[ | |SmokedROA_Threshold=[[Smoked threshold dose::2]] [[Smoked dose units::mg]] | ||
|SmokedROA_Light=[[ | |SmokedROA_Light=[[Smoked min light dose::5]] - [[Smoked max light dose::10]] mg | ||
|SmokedROA_Common=[[ | |SmokedROA_Common=[[Smoked min common dose::10]] - [[Smoked max common dose::20]] mg | ||
|SmokedROA_Strong=[[ | |SmokedROA_Strong=[[Smoked min strong dose::20]] - [[Smoked max strong dose::25]] mg | ||
|SmokedROA_Heavy=[[ | |SmokedROA_Heavy=[[Smoked heavy dose::25]] mg +<span style="color:red"> '''Heavy doses may result in psychosis and mania.'''<ref name="psychosis">3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential</ref></span> | ||
|SmokedROA_TimelineFile= | |SmokedROA_TimelineFile= | ||
|SmokedROA_TimelineWidth= | |SmokedROA_TimelineWidth= | ||
|SmokedROA_Duration=[[ | |SmokedROA_Duration=[[Smoked min total time::45]] - [[Smoked max total time::120]] [[Smoked total time units::minutes]] | ||
|SmokedROA_Onset= | |SmokedROA_Onset= | ||
|SmokedROA_Comeup= | |SmokedROA_Comeup= |
Latest revision as of 23:55, 12 May 2022
SubstanceBox/3-MeO-PCP | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | 3-MeO-PCP, 3-MeO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 1-[1-(3-Methoxyphenyl)cyclohexyl]-piperidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
- ↑ 1.0 1.1 1.2 3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential